The FASEB Journal,
Journal Year:
2023,
Volume and Issue:
37(9)
Published: Aug. 29, 2023
Endometriosis
is
a
common
estrogen-dependent
disorder
wherein
uterine
lining
tissue
(endometrium)
found
mainly
in
the
pelvis
where
it
causes
inflammation,
chronic
pelvic
pain,
pain
with
intercourse
and
menses,
infertility.
Recent
evidence
also
supports
systemic
inflammatory
component
that
underlies
associated
co-morbidities,
e.g.,
migraines
cardiovascular
autoimmune
diseases.
Genetics
environment
contribute
significantly
to
disease
risk,
explosion
of
omics
technologies,
underlying
mechanisms
symptoms
are
increasingly
being
elucidated,
although
novel
effective
therapeutics
for
infertility
have
lagged
behind
these
advances.
Moreover,
there
stark
disparities
diagnosis,
access
care,
treatment
among
persons
color
transgender/nonbinary
identity,
socioeconomically
disadvantaged
populations,
adolescents,
disturbing
low
awareness
health
care
providers,
policymakers,
lay
public
about
endometriosis,
which,
if
left
undiagnosed
under-treated
can
lead
significant
fibrosis,
infertility,
depression,
markedly
diminished
quality
life.
This
review
summarizes
endometriosis
epidemiology,
compelling
its
pathogenesis,
pathophysiology
age
precision
medicine,
recent
biomarker
discovery,
therapeutic
approaches,
issues
around
reproductive
justice
marginalized
populations
this
spanning
past
100
years.
As
we
enter
next
revolution
biomedical
research,
rich
molecular
clinical
datasets,
single-cell
omics,
population-level
data,
well
positioned
benefit
from
data-driven
research
leveraging
computational
artificial
intelligence
approaches
integrating
data
predicting
response
medical
surgical
therapies,
prognosis
recurrence.
Trends in Molecular Medicine,
Journal Year:
2024,
Volume and Issue:
30(9), P. 875 - 889
Published: July 10, 2024
Endometriosis
is
a
common
disorder
associated
with
pain,
gastrointestinal
and
urinary
symptoms,
infertility,
fatigue.
It
defined
by
the
presence
of
endometrial-like
lesions
found
predominantly
in
pelvis.
Mechanisms
that
contribute
to
disease
aetiology
include
changes
hormonal,
inflammatory,
pain
pathways.
In
this
article,
we
focus
on
recent
developments
imaging
technologies,
our
improved
understanding
mechanisms
contributing
drug
therapies
are
clinical
trials,
insights
from
studies
gut
offer
potential
support
self-management
strategies.
We
postulate
improvements
quality
life
patients
will
be
accelerated
reframing
endometriosis
as
multi-system
learning
treatments
targeting
symptoms
shared
between
endometriosis,
neuroinflammatory,
disorders.
Frontiers in Endocrinology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 10, 2025
Endometriosis,
the
most
prevalent
cause
of
infertility,
is
associated
with
anatomical
distortion
leading
to
adhesions
and
fibrosis,
as
well
endocrine
abnormalities
immune
disorders.
This
review
discusses
mechanisms
underlying
endometriosis-related
infertility.
Firstly,
alterations
in
hypothalamic-pituitary-ovarian
axis
lead
secretion
gonadotropins
steroid
hormones,
adverse
effects
on
ovulation
implantation,
fertility
decline.
Secondly,
dysregulation
hypothalamic-pituitary-adrenal
induces
elevated
serum
cortisol
prolactin
levels
patients
endometriosis,
accounting
for
its
regulation
stress,
depression,
anxiety.
Abnormal
interactions
between
endometrial
cells
system
change
local
microenvironment,
resulting
epithelial-mesenchymal
transition
inflammation.
Activated
epithelial
cells,
stromal
immunocytes
produce
various
chemokines,
cytokines,
or
autoantibodies,
creating
an
unfavorable
environment
embryo
implantation.
These
findings
suggest
that
spectrum
play
a
crucial
role
Thirdly,
oxidative
stress
has
ovarian
reserve
subsequent
embryonic
development,
predicting
another
promising
strategy
An
unbalanced
redox
state,
including
impaired
mitochondrial
function,
dysregulated
lipid
metabolism,
iron-induced
generates
pro-oxidative
which
negatively
impacts
oocyte
quality
sperm
viability.
Thus,
updated
understanding
involved
this
disease
will
help
develop
effective
strategies
manage
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(13), P. 7068 - 7068
Published: June 27, 2024
Endometriosis
is
a
chronic
inflammatory
disorder
characterized
by
the
abnormal
growth
of
endometrial-like
tissue
outside
uterine
cavity,
affecting
10-15%
women
reproductive
age.
Pain
most
common
symptom.
Treatment
options
include
surgery,
which
has
limited
effectiveness
and
high
recurrence
rates,
pharmacotherapy.
Hormonal
therapies,
commonly
used
for
symptom
management,
can
have
side
effects
contraceptive
outcomes,
contributing
to
infertility
associated
with
endometriosis,
pain
lesions
often
reappearing
after
treatment
cessation.
Among
its
etiological
factors,
immunological
dysregulation
plays
significant
role,
representing
an
interesting
target
developing
new
therapeutic
strategies.
This
review
critically
analyzes
recent
studies
provide
updated
synthesis
ongoing
research
into
potential
pharmacotherapies
focusing
on
lesion
progression,
relief,
improving
quality
life.
Immunotherapy,
natural
anti-inflammatory
antioxidant
compounds
drug
repurposing
show
promise
in
addressing
limitations
current
treatments
targeting
potentially
offering
non-invasive
solutions
managing
endometriosis.
Promising
results
been
obtained
from
vitro
animal
model
studies,
but
clinical
trials
are
still
limited.
More
effort
needed
translate
these
findings
practice
effectively
reduce
disease
alleviate
symptoms
preserve
capacity,
patients'
overall
wellbeing.
BMC Medicine,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: July 18, 2024
Abstract
Background
Endometriosis,
defined
as
the
presence
of
endometrial-like
tissue
outside
uterus,
is
one
most
prevalent
gynecological
disorders.
Although
different
theories
have
been
proposed,
its
pathogenesis
not
clear.
Novel
studies
indicate
that
gut
microbiome
may
be
involved
in
etiology
endometriosis;
nevertheless,
connection
between
microbes,
their
dysbiosis,
and
development
endometriosis
understudied.
This
case–control
study
analyzed
women
with
without
to
identify
microbial
targets
disease.
Methods
A
subsample
1000
from
Estonian
Microbiome
cohort,
including
136
864
control
women,
was
analyzed.
Microbial
composition
determined
by
shotgun
metagenomics
functional
pathways
were
annotated
using
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
database.
Partitioning
Around
Medoids
(PAM)
algorithm
performed
cluster
profile
population.
The
alpha-
beta-diversity
differential
abundance
analyses
assess
(species
KEGG
orthologies
(KO))
both
groups.
Metagenomic
reads
mapped
estrobolome-related
enzymes’
sequences
potential
microbiome-estrogen
metabolism
axis
alterations
endometriosis.
Results
Diversity
did
detect
significant
differences
(alpha-diversity:
all
p
-values
>
0.05;
beta-diversity:
PERMANOVA,
R
2
<
0.0007,
0.05).
No
species
or
detected
after
multiple
testing
adjustment
(all
FDR
Sensitivity
analysis
excluding
at
menopause
(>
50
years)
confirmed
our
results.
Estrobolome-associated
sequence
significantly
groups
Conclusions
Our
findings
do
provide
enough
evidence
support
existence
a
microbiome-dependent
mechanism
directly
implicated
To
best
knowledge,
this
largest
metagenome
on
conducted
date.
Frontiers in Endocrinology,
Journal Year:
2024,
Volume and Issue:
15
Published: May 28, 2024
Background
and
Aims
The
association
of
the
triglyceride-glucose
(TyG)
index,
a
promising
novel
biomarker
for
insulin
resistance,
with
risk
endometriosis
has
not
been
investigated
to
date.
This
nationwide
study
aimed
explore
between
TyG
index
risk.
Methods
Data
were
obtained
from
National
Health
Nutrition
Examination
Survey
(1999–2006).
Female
participants
who
provided
complete
data
on
enrolled
in
analysis.
Multivariate
logistic
regression
analyses
utilized
assess
endometriosis,
adjusted
by
multiple
potential
confounders.
Meanwhile,
in-depth
subgroup
conducted.
Results
A
total
1,590
eligible
included,
among
whom
135
(8.5%)
women
diagnosed
endometriosis.
fully
multivariate
model
showed
was
significantly
associated
(odds
ratio
[OR]
Q4
versus
Q1
2.04,
95%
confidence
interval
[CI]:
1.15–3.62;
P
trend=0.013).
In
analyses,
positive
also
found
parous
(OR
2.18,
CI:
1.20–3.96),
without
diabetes
2.12,
1.19–3.79),
smoke
currently
3.93,
1.33–11.58),
drink
2.54,
1.27–5.07),
use
oral
contraceptives
1.91,
1.04–3.51).
Additionally,
increasing
trends
odds
across
quartiles
observed
above-mentioned
subgroups
(all
trend<0.05).
Conclusions
population-based
that
higher
representing
an
increased
level
US
population.
Our
findings
suggested
might
be
tool
assessment
Prospective
studies
are
warranted
further
verify
these
findings.
Journal of Clinical Investigation,
Journal Year:
2024,
Volume and Issue:
134(21)
Published: Aug. 14, 2024
Endometriosis
is
a
debilitating,
chronic
inflammatory
disease
affecting
approximately
10%
of
reproductive-age
women
worldwide
with
no
cure.
While
macrophages
have
been
intrinsically
linked
to
the
pathophysiology
endometriosis,
targeting
them
therapeutically
has
extremely
challenging
due
their
high
heterogeneity
and
because
these
disease-associated
(DAMs)
can
be
either
pathogenic
or
protective.
Here,
we
report
identification
characterized
by
TET3
overexpression
in
human
endometriosis
lesions.
We
show
that
factors
from
microenvironment
upregulated
expression,
transforming
into
DAMs.
stimulated
proinflammatory
cytokine
production
via
feedback
mechanism
involving
inhibition
let-7
miRNA
expression.
Remarkably,
cells
relied
on
for
survival
hence
were
vulnerable
knockdown.
demonstrated
Bobcat339,
synthetic
cytosine
derivative,
triggered
degradation
both
mouse
macrophages.
This
was
dependent
von
Hippel-Lindau
(VHL)
E3
ubiquitin
ligase
whose
expression
also
TET3-overexpressing
Furthermore,
depleting
through
myeloid-specific
Tet3
ablation
using
Bobcat339
strongly
inhibited
progression
mice.
Our
results
defined
as
key
contributors
attractive
therapeutic
targets
endometriosis.
findings
may
applicable
other
diseases
where
DAMs
important
roles.
JAMA Psychiatry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 5, 2025
Importance
Although
psychological
traumas
have
been
associated
with
endometriosis,
limited
information
is
available
regarding
the
role
of
trauma
type
and
genetic
predisposition.
Objective
To
examine
relationship
between
traumatic
experiences
endometriosis
using
observational
genetically
informed
analyses.
Design,
Setting,
Participants
For
this
case-control
study,
analyses
were
performed
May
13,
2023,
September
30,
2024.
Genotypic
phenotypic
was
combined
from
UK
Biobank
individual-level
data
(up
to
8276
patients
240
117
female
controls)
genome-wide
a
large
meta-analysis
(European
ancestry:
21
779
449
087
controls;
East
Asian
1713
1581
FinnGen
cohort
(16
588
111
583
controls
European
descent).
Main
Outcomes
Measures
Phenotypic
associations
via
multiple
regression;
latent-class
analysis
(LCA)
investigate
co-occurrence
patterns
different
in
cases
correlation
polygenic
risk
scoring
(PRS)
assess
pleiotropy
linking
events
endometriosis.
Results
Up
women
(mean
[SD]
age,
53.2
[13.0]
years)
56.5
[9.6]
investigated
study.
Women
more
likely
report
childhood
adulthood
stressful
(eg,
contact
odds
ratio
[OR],
1.28;
95%
CI,
1.02-1.26).
Our
LCA
highlighted
association
emotional
physical
(225
[8%]
vs
3948
[5%];
P
&lt;
2.2
×
10
−16
)
sexual
(414
[5%]
3158
[4%];
=
2.9
−3
).
Unaffected
(controls)
assigned
“no
trauma”
latent
class
(563
[20%]
18
949
[24%];
7.4
−14
(rg)
linked
trauma-related
outcomes,
including
posttraumatic
stress
disorder
(meta-analysis
rg
0.31,
7.1
;
0.26,
4.7
−15
maltreatment
0.23,
1.3
−6
0.16,
1
−4
Endometriosis
PRS
increased
disease
(β
),
but
no
interaction
observed
types
events.
Conclusions
Relevance
The
present
study
comprehensively
impact
on
In
particular,
our
findings
highlight
potential
which
appears
be
independent
Актуальні питання педіатрії акушерства та гінекології,
Journal Year:
2025,
Volume and Issue:
2, P. 38 - 47
Published: Jan. 22, 2025
Мета
дослідження
–
підвищити
ефективність
органозберігаючого
хірургічного
лікування
жінок
із
глибоким
ендометріозом,
що
супроводжується
больовим
синдромом,
шляхом
створення
покрокового
алгоритму
оперативного
лапароскопічного
втручання.
Матеріали
та
методи.
На
базі
нашого
центру
було
проведено
проспективне
обсерваційне
одноцентрове
когортне
дослідження,
до
якого
увійшли
210
репродуктивного
віку
прооперованих
приводу
глибокого
ендометріозу
за
новою
методикою
стандартизації
період
січня
2020
грудня
2023
р.,
класифікацію
всіх
випадків
проводили
згідно
з
#Enzian.
Досліджено
інтраопераційні,
ранні
віддалені
післяопераційні
показники.
Результати
їх
обговорення.
Ми
отримали
значне
статистично
значуще
поліпшення
показників
больового
синдрому
через
6
місяців
після
втручання
шкалою
ВАШ
від
0
10
(хронічний
тазовий
біль
операції
6,87+/-1,41,
2,41+/-1,59
(p<0,001),
дисменорея
8,46+/-1,16
2,08+/-1,36
диспареунія
7,42+/-1,07
2,22+/-1,69
дисхезія
3,2+/-3,6
0,8+/-2,0
дизурія
1,2+/-2,6
0,4+/-1,4
(p=0,026)).
Глибокий
ендометріоз
є,
безумовно,
найтяжчою
формою
визначається
як
розростання
тканини,
схожої
на
ендометрій,
по
під
поверхнею
очеревини;
зазвичай
це
вузли,
здатні
проникати
у
сусідні
структури
пов’язані
фіброзом
і
порушенням
нормальної
анатомії,
чим
зумовлена
складність
цього
захворювання.
Ураження
органів
тканинних
структур
призводить
змін
анатомії
елімінацією
контурів
значного
спотворення
операційного
поля,
становить
серйозну
проблему
при
хірургічному
лікуванні
навіть
для
досвідчених
хірургів.
Це,
звичайно,
треба
враховувати
перед-
інтраопераційному
етапі.
Наразі
не
існує
регламентованих
документів
світі
щодо
ендометріозу,
а
саме
стандартизованих
підходів
такого
однозначної
думки
про
ступінь
радикальності
операцій.
Щодо
хірургії
ми
маємо
єдиний
документ
ESGE,
ESHRE
and
WES
2020,
але
він
присвячений
деяким
технічним
особливостям
містить
стратегії
втручання,
яка
є
вкрай
необхідною
хірурга.
Оскільки
кожен
хірург
оперує
пацієнток
спираючись
свій
власний
розсуд,
таке
може
мати
занадто
суб’єктивний
характер
завжди
йти
користь
пацієнтам,
тому
вважаємо,
настав
час
ендометріозу.
Наступним
нашим
дослідженням
стане
ретроспективне
порівняння
хірургічних
пацієнток,
стандартизованою
загальноприйнятими
методами.
Висновки.
Алгоритм
стандартизованого
має
покращити
показники
результати,
значно
полегшити
роботу
хірургів
об’єктивізувати
лікування.